Treatment results in children with B-cell lymphomas using a modified BFM protocol
Belogurova, M.B.; Raulesku, G.G.; Kirichenko, M.M.; Viktorovich, T.D.; Goroshko, G.N.; Chavpetsova, E.D.; Kolygin, B.A.
Terapevticheskii Arkhiv 70(7): 39-41
1998
ISSN/ISBN: 0040-3660 PMID: 9742634 Document Number: 495426
Trial of the modified protocol BFM in the treatment of children with B-cell lymphomas. 26 children with B-cell lymphoma were treated. Of them 2 children were treated according to the program for risk 2 group and 24 children were treated as risk 3 group. Complete remission was achieved in 23 patients. Two children were resistant. There were 2 cases of early recurrence, 1 case of early death, 1 case of death in remission. 20 patients are in complete remission. The 4-year survival is 78%. The modified protocol BFM proved to be highly effective against B-cell lymphoma in children. Its drawback is high toxicity.